Cargando…

Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma

SIMPLE SUMMARY: Uveal melanoma (UM) is a rare aggressive eye cancer. Although treatment of the eye tumour is successful, about 50% of UM patients develop a relapse of their cancer in the liver. At present, such advanced disease is not curable. A better understanding of the metastatic UM (mUM) in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishna, Yamini, Acha-Sagredo, Amelia, Sabat-Pośpiech, Dorota, Kipling, Natalie, Clarke, Kim, Figueiredo, Carlos R., Kalirai, Helen, Coupland, Sarah E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650807/ https://www.ncbi.nlm.nih.gov/pubmed/33008022 http://dx.doi.org/10.3390/cancers12102832

Ejemplares similares

Investigating the Role of DUSP4 in Uveal Melanoma
por: Aughton, Karen, et al.
Publicado: (2022)

Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention
por: Sabat‐Pośpiech, Dorota, et al.
Publicado: (2022)

Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections
por: Zhang, Hongrun, et al.
Publicado: (2020)

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
por: Figueiredo, Carlos R, et al.
Publicado: (2020)

Vascular Lakes in Uveal Melanoma and Their Association With Outcome
por: Jones, Hayley, et al.
Publicado: (2022)

MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators
por: Aughton, Karen, et al.
Publicado: (2020)

A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
por: Rola, Alda Cunha, et al.
Publicado: (2022)

Inhibition of ATM Increases the Radiosensitivity of Uveal Melanoma Cells to Photons and Protons
por: Hussain, Rumana N., et al.
Publicado: (2020)

Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
por: Farquhar, Neil, et al.
Publicado: (2017)

In-depth proteomic profiling of the uveal melanoma secretome
por: Angi, Martina, et al.
Publicado: (2016)

Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture
por: Aughton, Karen, et al.
Publicado: (2020)

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
por: Kalirai, H, et al.
Publicado: (2014)

Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma
por: Thornton, Sophie, et al.
Publicado: (2020)

Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers
por: Jang, Geeng-Fu, et al.
Publicado: (2021)

Small High-Risk Uveal Melanomas Have a Lower Mortality Rate
por: Hussain, Rumana N., et al.
Publicado: (2021)

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma
por: Robinson, Helena, et al.
Publicado: (2023)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
por: Yin, Jie, et al.
Publicado: (2023)

Identification of prognostic genes in uveal melanoma microenvironment
por: Luo, Huan, et al.
Publicado: (2020)

Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma
por: Goesmann, Lara, et al.
Publicado: (2023)

Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target
por: Groenewoud, Arwin, et al.
Publicado: (2023)

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021)

High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
por: Slater, Kayleigh, et al.
Publicado: (2020)

Long-Term Survivors with Metastatic Uveal Melanoma
por: Buzzacco, Dominic M, et al.
Publicado: (2012)

Treatment of Metastatic Uveal Melanoma: Systematic Review
por: Rodriguez-Vidal, Cristina, et al.
Publicado: (2020)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Commentary: Prognostication of uveal melanoma based on molecular diagnosis - Are we there yet?
por: Attiku, Yamini, et al.
Publicado: (2019)

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
por: van Essen, T. Huibertus, et al.
Publicado: (2016)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
por: Gezgin, Gülçin, et al.
Publicado: (2017)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
por: Damato, Bertil E., et al.
Publicado: (2019)

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
por: Fagone, Paolo, et al.
Publicado: (2017)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Darovasertib, a novel treatment for metastatic uveal melanoma
por: Cao, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dtt79j0md9nkdp8no2q14ugt7r